GRAIL, Inc. (GRAL)
Automate Your Wheel Strategy on GRAL
With Tiblio's Option Bot, you can configure your own wheel strategy including GRAL - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol GRAL
- Rev/Share 3.8099
- Book/Share 70.352
- PB 0.5613
- Debt/Equity 0.0266
- CurrentRatio 9.705
- ROIC -0.7267
- MktCap 1420593318.0
- FreeCF/Share -13.6294
- PFCF -3.038
- PE -0.7077
- Debt/Assets 0.0226
- DivYield 0
- ROE -0.7507
- Rating B-
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 3
- P/B Score 5
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | GRAL | Canaccord Genuity | -- | Buy | -- | $32 | April 21, 2025 |
| Initiation | GRAL | Guggenheim | -- | Neutral | -- | -- | Oct. 17, 2024 |
News
GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing
Published: February 25, 2025 by: PRNewsWire
Sentiment: Neutral
MENLO PARK, Calif. , Feb. 25, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL) a healthcare company whose mission is to detect cancer early when it can be cured, has partnered with award-winning actress Kate Walsh to launch Generation Possible, an educational initiative to raise awareness of multi-cancer early detection (MCED) testing.
Read More
GRAIL to Present at TD Cowen 45th Annual Health Care Conference
Published: February 21, 2025 by: PRNewsWire
Sentiment: Neutral
MENLO PARK, Calif. , Feb. 21, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the TD Cowen 45th Annual Health Care Conference in Boston on Tuesday, Mar. 4 at 9:10 a.m.
Read More
GRAIL, Inc. (GRAL) Q4 2024 Earnings Call Transcript
Published: February 20, 2025 by: Seeking Alpha
Sentiment: Neutral
GRAIL, Inc. (NASDAQ:GRAL ) Q4 2024 Earnings Conference Call February 20, 2025 4:30 PM ET Company Participants Bob Ragusa - Chief Executive Officer and Board Member Aaron Freidin - Chief Financial Officer Joshua Ofman - President Sir Harpal Kumar - President of International Business and BioPharma Conference Call Participants Doug Schenkel - Wolfe Research Operator Good day, ladies and gentlemen, and welcome to the GRAIL Fourth Quarter 2024 Earnings Call. At this time, all participants are in listen-only mode.
Read More
GRAIL Reports Fourth Quarter and Full Year 2024 Financial Results
Published: February 20, 2025 by: PRNewsWire
Sentiment: Neutral
Sold More than 137,000 Galleri® Tests in 2024, Growing U.S. Galleri Revenue 45% Year-Over-Year to $108.6 Million Completed Study Visits for Two Registrational Studies in July to Support Modular PMA Submission for Galleri On Track for Continued Commercial Growth in 2025 with TRICARE Coverage and Recent Announcement of Quest Integration Moderated Cash Burn, Ending 2024 with a Cash Position of $767M, Extending Runway into 2028 MENLO PARK, Calif. , Feb. 20, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial results for …
Read More
GRAIL to Announce Fourth Quarter 2024 Financial Results
Published: February 12, 2025 by: PRNewsWire
Sentiment: Neutral
MENLO PARK, Calif. , Feb. 12, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue financial results for the fourth quarter 2024 following the close of market on Thursday, Feb. 20, 2025.
Read More
About GRAIL, Inc. (GRAL)
- IPO Date 2024-06-12
- Website https://grail.com
- Industry Medical - Diagnostics & Research
- CEO Mr. Robert P. Ragusa
- Employees 1000